U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
FIRTECAN PEGOL
WC4978T687
Investigational
General
Names
6
Classification
2
Identifiers
10
Display Structure
Related Substances
2
FIRTECAN PEGOL
WC4978T687
Investigational
General
Approval Year
Unknown
149,124
Names
6
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
FIRTECAN PEGOL
Official Name
English
EZN-2208
Preferred Name
English
firtecan pegol [INN]
Common Name
English
Firtecan pegol [WHO-DD]
Common Name
English
PEG-SN38
Common Name
English
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Classification
2
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Treatment of neuroblastoma.
FDA ORPHAN DRUG
338311
Topoisomerase Inhibitor
Pharmacologic Substance
[C1909]
Enzyme Inhibitor
[C471]
Topoisomerase Inhibitor
[C1748]
Topoisomerase-I Inhibitor
NCI_THESAURUS
C1904
Showing 1 to 2 of 2 entries
Previous
1
Next
Identifiers
10
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
PUBCHEM
59443782
PRIMARY
USAN
YY-75
PRIMARY
FDA UNII
WC4978T687
PRIMARY
NCI_THESAURUS
C70651
PRIMARY
SMS_ID
100000175529
PRIMARY
Showing 1 to 5 of 10 entries
Previous
1
2
Next
Display Structure
Export Data
Related Substances
2
METABOLITE ACTIVE (PRODRUG)
0H43101T0J
7-ETHYL-10-HYDROXYCAMPTOTHECIN
SUBSTANCE RECORD
WC4978T687
FIRTECAN PEGOL
